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Beta-blockers are chiral compounds with enantiomers that have different bioactivity, which means that while one is active, 
the other can be inactive or even harmful. Due to their high consumption and incomplete degradation in waste water, they 
may reach surface waters and affect aquatic organisms. To address this issue we developed a chromatographic method 
suitable for determining beta-blocker enantiomers in surface waters. It was tested on five beta-blockers (acebutolol, 
atenolol, bisoprolol, labetalol and metoprolol) and validated on bisoprolol enantiomers. Good enantioseparation of all 
analysed beta-blockers was achieved on the Chirobiotic V column with the mobile phase composed of methanol/acetic 
acid/triethylamine (100/0.20/0.15 v/v/v) at a flow rate of 0.5 mL/min and column temperature of 45 °C. Method proved 
to be linear in the concentration range from 0.075 µg/mL to 5 µg/mL, and showed good recovery. The limits of bisoprolol 
enantiomer detection were 0.025 µg/mL and 0.026 µg/mL and of quantification 0.075 µg/mL and 0.075 µg/mL. Despite 
its limitations, it seems to be a promising method for bisoprolol enantiomer analysis in surface water samples. Further 
research could focus on waste water analysis, where enantiomer concentrations may be high. Furthermore, transferring 
the method to a more sensitive one such as liquid chromatography coupled with tandem mass spectrometry and using 
ammonium acetate as the mobile phase additive instead of acetic acid and triethylamine would perhaps yield much lower 
limits of detection and quantification.
KEY WORDS: acebutolol; atenolol; Chirobiotic V column; Croatia; Czech Republic; enantioseparation; HPLC; labetalol; 
metoprolol; water analysis
Beta-adrenergic blocking agents, more commonly 
known as beta-blockers, are cardiovascular drugs used for 
the treatment of hypertension and coronary artery diseases 
such as angina pectoris and acute myocardial infarction (1). 
These compounds are chiral, with one or more stereogenic 
centres. As with many other chiral pharmaceuticals, one 
enantiomer can be bioactive while the other can be inactive 
or even toxic. For example, (S)-propranolol is 100 times 
more potent than (R)-propranolol. In addition, since (R)-
propranolol can inhibit the conversion of thyroxin to 
triiodothyronine, it can be used to treat hyperthyroidism in 
patients with bradycardia, asthma, or where the use of 
racemate is contraindicated due to the adrenergic effect of 
(S)-propranolol (2).
Since beta-blockers are among the most common 
pharmaceuticals, high levels of the unchanged compound 
and their metabolites may end up in waste waters through 
excretion. Although waste waters are processed in waste 
water treatment plants, some pollutants are not completely 
removed, and beta-blockers may reach surface waters (3). 
In the last decade, beta-blockers have received an increasing 
attention as emerging pollutants, as exposure to higher 
levels can affect the growth, reproduction, heart rate, and 
cause stress response in some fish and mollusc species (4).
Currently, risk assessments of chiral pharmaceuticals 
are limited to racemates, even though individual enantiomers 
can have different effects on aquatic organisms. Furthermore, 
human metabolism or waste water treatment can convert 
one enantiomer into its counterpart (chiral inversion) and 
their 1:1 ratio may change in favour of one or another in 
surface waters. This is why future risk assessments of 
pharmaceuticals should extend their scope to individual 
enantiomers.
There are but a few studies reporting on enantiospecific 
toxicity of beta-blockers. Stanley et al. (5) reported three 
times greater toxicity of (S)-propranolol on Pimephales 
promelas growth rate than the (R)-enantiomer. In contrast, 
de Andrés et al. (6) reported four times greater toxicity of 
(R)-atenolol on Tetrahymena thermophila (6). Sun et al. (7) 
could not find enantiospecific toxicity of propranolol and 
metoprolol to embryos and larvae of Danio rerio but did 
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observe changes in gene transcriptions that might indicate 
enantioselectivity.
Separation of enantiomers in beta-blockers has already 
been studied to some extent. Methods that are used are 
liquid chromatography (LC) with ultraviolet–visible 
spectrophotometry (UV/VIS) or mass spectrometry (MS) 
and capillary electrophoresis. The most common are direct 
LC methods with various chiral stationary phases based on 
polysaccharides (8‒11), cyclodextrins (12), or macrocyclic 
antibiotics (13‒16). Enantiomers can be separated in normal 
or reverse phase modes with various solvents such as hexane 
or acetonitrile and methanol, respectively. Various additives 
such as triethylamine, diethylamine, or acetic acid, can also 
be added to improve the resolution of enantiomers (8‒16).
There are only a few papers describing the analysis of 
enantiomers of beta blockers in waste and surface waters. 
Water samples are purified and pre-concentrated by solid 
phase extraction using different kinds of cartridges (11, 
17‒18).
Since bisoprolol is the most commonly used beta-
blocker in Croatia and Czech Republic (19, 20), its 
occurrence in surface and waste waters in these countries 
is quite likely. Methods used so far for bisoprolol 
determination in waste and river waters included LC 
coupled with triple quadrupole (21‒22) and gas 
chromatography (GC) coupled with MS (23), but none 
involved chiral separation and could not provide information 
about single enantiomer content. Methods that have been 
used for chiral separation have only been validated for 
determining bisoprolol content in pharmaceutical products 
(9, 16).
Here we present a chromatographic method we 
developed for chiral separation of five beta-blockers 
(acebutolol, atenolol, bisoprolol, labetalol, and metoprolol) 
and its validation for bisoprolol enantiomer determination 




Standards of (±)-atenolol, (±)-acebutolol, (±)-labetalol 
and (±)-bisoprolol were purchased from Sigma-Aldrich (St. 
Louis, MO, USA) and (±)-metoprolol tartrate was purchased 
from Tokyo Chemical Industry (Tokyo, Japan). All 
standards were of high-purity grade (>98 %). High-purity 
grade (99 %) triethylamine (TEA) was purchased from 
Tokyo Chemical Industry, and glacial acetic acid (HAc) 
from Alkaloid AD Skopje (Skopje, North Macedonia). 
HPLC-purity grade methanol (MeOH) was purchased from 
J. T. Baker (Gliwice, Poland). Sodium hydroxide was of 
p.a. grade and purchased from Kemika (Zagreb, Croatia). 
Ultrapure water was obtained from a Milli-Q Advantage 
A10 purification system (Merck, Kenilworth, NJ, USA).
Standard solutions
Stock solutions of standards were prepared by weighing 
the appropriate amount of each beta-blocker and dissolving 
it in methanol to give the final concentration of 1 mg/mL. 
The method was optimised with standard solutions prepared 
by diluting stock solution with methanol to achieve the final 
concentration of 100 µg/mL. For method validation and 
determination of bisoprolol in surface waters, standard 
solutions were prepared by diluting the stock solution with 
methanol to achieve desired concentrations.
Sample preparation
Water samples were taken from the Sava River in 
Zagreb, Croatia and from the Kunraticky stream (Kunratice) 
and a nearby biological pond in Prague, Czech Republic. 
The stream runs near a hospital and receives wastewater 
discharged from its treatment system. Samples were 
collected upstream and downstream of the discharge 
location and were filtered through 12 µm pore size filter 
paper and stored at 4 °C until analysis.
Samples were prepared for analysis following a 
modified method by Meierjohann et al. (21). Before 
preparation, we adjusted the pH of water samples and of 
ultrapure water for solid phase extraction (SPE) to 10 with 
a 1 mol/L solution of sodium hydroxide. For solid phase 
extraction we used the Oasis HLB cartridges (6 mL, 
500 mg) (Waters Corporation, Milford, MA, USA). 
Cartridges were preconditioned with methanol and ultrapure 
water. A sample volume of 250 mL was loaded on the 
cartridges at a flow rate of about 10 mL/min. After washing 
the cartridges with ultrapure water and drying them with 
vacuum, beta-blockers were eluted with methanol (6 mL). 
Aliquots were transferred to vials and analysed with a high-
performance liquid chromatograph (HPLC).
Method development, instrumentation, and 
chromatographic conditions
We used an Agilent 1220 Infinity series HPLC system 
(Agilent Technologies, Santa Clara, CA, USA) equipped 
with a binary pump, an autosampler, a thermostated column 
compartment, and a variable wavelength detector.
To develop the best HPLC method for chiral separation 
of beta-blockers acebutolol (ACE), atenolol (ATE), 
metoprolol (MET), labetalol (LAB) and bisoprolol (BIS) 
we evaluated four columns [Chiralpak IA and Chiralpak IC 
(Chiral Technologies Europe, Strasbourg, France) and 
Chirobiotic T and Chirobiotic V (Advanced Separation 
Technologies Inc., Whippany, NJ, USA)] with different 
mobile phases (consisting of n-hexane and methanol or 
ethanol) and different mobile phase additives (triethylamine, 
diethylamine, acetic acid, or isopropylamine). Seeing that 
the best results in terms of separation of all enantiomers 
were achieved on the Chirobiotic V column using polar 
ionic mode, where the mobile phase consisted of methanol 
and small amounts of acid and base, we then also evaluated 
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(IQL) were obtained with the S/N ratio method by preparing 
and injecting standard solution five times. The suggested 
concentration was confirmed as IQL if the S/N ratio was 
above 10 every time.
RESULTS
The best results in terms of enantiomer separation were 
achieved with the Chirobiotic V column and mobile phase 
consisting of methanol/acetic acid/triethylamine in ratio 
100:0.20:0.15 (v/v/v) with flow rate of 0.5 mL/min and 
column temperature of 45 °C. Table 1 shows the retention 
factor (k), resolution (Rs), and selectivity factor (α) for each 
analyte. The retention times of all analytes were within 
acceptable limits and lasted from 10 to 25 min. Baseline 
enantiomer separation was achieved with all beta-blockers 
but labetalol (having two stereogenic centres, i.e. four 
enantiomers), whose first two enantiomers were only 
partially separated (Figure 2).
We also tried analysing a mixture of enantiomers of all 
four beta blockers. The results were good for all analytes 
but the metoprolol and bisoprolol enantiomers, as one 
bisoprolol enantiomer co-eluted with one metoprolol 
enantiomer. We then tried different ratios of acetic acid and 
triethylamine and different flow rates and column 
temperatures but none improved the separation in the 
mixture.
Because of this reason and because bisoprolol is the 
most common beta-blocker in Croatia and Czech Republic 
and is the most likely to contaminate surface waters in these 
countries, we proceeded with method validation for 
bisoprolol alone.
As the standard solution we used was a racemic mixture, 
we could not identify the elution order of (R)- and (S)-
enantiomers, so we named the first eluted enantiomer BIS1 
and the second BIS2. Enantiomeric fractions of BIS1 and 
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different ratios of acetic acid and triethylamine or 
diethylamine and the effects of column temperature and 
flow rate on enantioseparation for all of the analysed beta-
blockers. This narrowed down the choice to the Chirobiotic 
V column (5 μm thick, 250×4.6 mm), mobile phase 
consisting of methanol plus acetic acid and triethylamine 
in the ratio 100:0.20:0.15 (v/v/v), flow rate of 0.5 mL/min, 
and column temperature of 45 °C. Detection was performed 
at 230 nm. The injection volume was 10 µL.
Method validation
The method was validated for determination of 
bisoprolol enantiomers. Enantiomeric fractions were 
calculated using equation [1]:
EF= E1 x 100 % [1]E1 + E2
where E1 and E2 were the peak areas of the first and second 
eluting enantiomers of bisoprolol, respectively.
Linearity was tested on six standard solutions in the 
concentration range from 0.075 µg/mL to 5 µg/mL. Linear 
regression was tested by plotting peak areas against these 
six concentrations.
Instrumental limits of detection (IDL) were determined 
based on the calibration curve, as described in the 
International Council for Harmonisation of Technical 
Requirements for Pharmaceuticals for Human Use (ICH) 
guidelines (24), from equation [2]:
IDL= 3.3 σ [2]S
where σ was residual standard deviation of a regression 
line, and S the slope estimated from the calibration curve 
in the concentration range from 0.025 µg/mL to 0.25 µg/
mL. The calculated IDL was confirmed by analysing 
standard solutions of bisoprolol enantiomers prepared at 
IDL concentrations. After injecting a standard solution five 
times, IDL was confirmed if the signal-to-noise ratio (S/N) 
was above 3 every time. Instrumental limits of quantification 
Table 1 Chromatographic parameters for beta-blockers separated on the Chirobiotic V column using the MeOH:HAc:TEA (100:0.2:0.15) 
mobile phase, flow rate of 0.5 mL/min, and column temperature of 45 °C (detection wavelength 230 nm)




































equal 0.6 µg/L and 1.8 µg/L in surface waters, respectively. 
Good linearity was achieved for both bisoprolol enantiomers 
in the concentration range of 0.075–5 µg/mL, with 
correlation coefficients above 0.998. This range equals 
1.8–120 µg/L of each bisoprolol enantiomer in surface 
waters.
To determine the applicability of this method for 
bisoprolol enantiomer analysis in real samples, we analysed 
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BIS2 were 49.7 % and 50.3 %, respectively, confirming the 
racemic nature of the standard solution.
The IDL of each bisoprolol enantiomer, determined by 
linear regression, was 0.025 µg/mL for BIS1 and 0.026 µg/
mL for BIS2. These limits were confirmed by injecting 
standard solution at calculated limit levels (0.025 µg/mL) 
with S/N ratios higher than 3. The IQL (S/N ratio >10) was 
0.075 µg/mL for both enantiomers. These concentrations 
Figure 1 Structures of the analysed beta-blockers (chiral centres are marked with an asterisk)
Figure 2 Chromatographic separation of acebutolol, atenolol, bisoprolol, labetalol, and metoprolol enantiomers on the Chirobiotic V 
column using the MeOH:HAc:TEA (100:0.2:0.15) mobile phase, flow rate of 0.5 mL/min, and column temperature of 45 °C (detection 
wavelength 230 nm)
60 Pocrnić M, et al. Chiral separation of beta-blockers by HPLC and determination of bisoprolol enantiomers in surface waters Arh Hig Rada Toksikol 2020;71:56-62
BIS2, which is an acceptable range (Table 2). Comparing 
the recoveries of different samples spiked with 12.00 µg/L 
of bisoprolol, we can conclude that this method of sample 
preparation yielded good repeatability, with relative 
standard deviation of <5 % for both enantiomers.
We also tested the method on surface water samples 
without spiking them with standard solutions but found no 
bisoprolol enantiomers. This finding will be addressed 
further in discussion.
DISCUSSION AND CONCLUSIONS
Although the method developed in this study showed 
better enantiomer separation for each beta-blocker alone 
than reported previously (1, 9), it failed in separating 
enantiomers in the mixture of metoprolol and bisoprolol 
the solid-phase extracts of surface water samples (taken in 
Prague and Zagreb) for bisoprolol content. Before solid-
phase extraction, however, we added known amounts of 
standard bisoprolol solution to samples of distilled and 
surface waters to determine the rate of elution of the analytes 
from cartridges. These samples were prepared in the same 
way as regular samples. The recoveries of bisoprolol 
enantiomers in spiked distilled water at the two 
concentrations (99–111 %) showed good extraction of 
bisoprolol.
Samples from the Sava were spiked at three 
concentrations, 1.80 µg/L (Sava 1), 6.00 µg/L (Sava 2), and 
12.00 µg/L (Sava 3). Samples from the Kunraticky stream 
(Prague 1 and Prague 3) and the nearby pond (Prague 2) 
were spiked at 12.00 µg/L or lower, according to Table 2. 
(Figure 3). The recoveries ranged from 100 % to 136 % for 
enantiomer BIS1 and from 99 % to 138 % for enantiomer 
Table 2 Expected and calculated concentrations of bisoprolol enantiomers and their recoveries in spiked samples of distilled and surface 







BIS 1 BIS 2 BIS 1 BIS 2 BIS 1 BIS 2
Distilled water 1 12.00 12.00 12.02 11.85 100.2 98.8
Distilled water 2 240.00 240.00 265.71 264.58 110.7 110.2
Prague 1 12.00 12.00 13.18 13.19 109.8 109.9
Prague 2 9.36 9.36 10.08 10.08 107.7 107.7
Prague 3 8.16 8.16 9.44 9.49 115.7 116.3
Sava 1 1.80 1.80 2.27 2.35 126.3 130.3
Sava 2 6.00 6.00 8.14 8.30 135.7 138.3
Sava 3 12.00 12.00 13.90 14.31 115.8 119.3
Figure 3 Chromatograms of samples from the Kunraticky stream (A) and the Sava River (B), spiked with bisoprolol enantiomers at 
12 µg/L after solid-phase extraction
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and should perhaps be limited to analysing bisoprolol alone, 
especially as its consumption and the associated risk of 
surface water contamination is the highest, at least in Croatia 
and the Czech Republic. Furthermore, the consumption of 
metoprolol is not very high in these countries, especially 
not in Croatia, and its occurrence in surface waters is 
unlikely, so it is not expected to interfere with bisoprolol 
enantiomer analysis in surface waters.
Our failure to find bisoprolol enantiomers in unspiked 
(and therefore real) surface water samples either suggests 
that bisoprolol is successfully removed in waste water 
treatment plants or points to another limitation of our 
method, which is that its detection limits are too high. 
Further analysis of waste water before and after treatment 
could give a better insight into the levels of bisoprolol 
occurring in these countries.
Even with these limitations, however, our method has 
shown adequate recoveries with spiked samples and could 
be used to determine bisoprolol enantiomers in surface 
waters, which, to our knowledge, has not been reported so 
far. Future research could therefore focus on bisoprolol 
enantiomer content in waste water collected by treatment 
plants, where its concentrations may be high. Furthermore, 
transferring the method to a more sensitive one – such as 
liquid chromatography coupled with tandem mass 
spectrometry and using ammonium acetate as the mobile 
phase additive instead of acetic acid and triethylamine – 
would perhaps yield much lower limits of detection and 
quantification (25).
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Kiralna separacija beta-blokatora tekućinskom kromatografijom visoke djelotvornosti i određivanje enantiomera 
bisoprolola u površinskim vodama
Beta-blokatori su kiralni spojevi s enantiomerima različite bioaktivnosti, dakle, dok je jedan enantiomer aktivan, drugi 
može biti neaktivan ili čak štetan za organizam. Zbog njihove visoke potrošnje i nepotpune razgradnje u pogonima za 
preradu otpadnih voda, postoji mogućnost da se pojave u prirodnim vodama i negativno utječu na vodene organizme. 
Stoga je u ovom radu razvijena kromatografska metoda za određivanje enantiomera beta-blokatora u prirodnim vodama. 
Metoda je testirana na pet beta-blokatora (acebutolol, atenolol, bisoprolol, labetalol i metoprolol) te validirana za 
enantiomere bisoprolola. Dobra enantioseparacija svih analiziranih beta-blokatora postignuta je na koloni Chirobiotic V 
sastava mobilne faze metanol/octena kiselina/trietilamin (100:0,2:0,15 v/v/v) pri protoku od 0,5 mL/min i temperaturi od 
45 °C. Metodom je postignuta dobra linearnost u području od 0,075 µg/mL do 5 µg/mL s dobrim analitičkim povratom. 
Granice detekcije pojedinih enantiomera bisoprolola bile su 0,025 µg/mL i 0,026 µg/mL, a granice kvantifikacije 0,075 µg/
mL za oba enantiomera. Unatoč ograničenjima metode, pokazala se kao obećavajuća metoda analize enantiomera 
bisoprolola u površinskim vodama. Daljnja istraživanja mogla bi se izvoditi na otpadnim vodama, gdje bi koncentracije 
enantiomera mogle biti više. Također, korištenjem osjetljivije metode, primjerice vezanoga sustava tekućinske 
kromatografije i tandemne spektrometrije masa, te korištenjem amonijeva acetata kao aditiva mobilnoj fazi umjesto octene 
kiseline i trietilamina, mogle bi se postići znatno niže granice detekcije i kvantifikacije. 
KLJUČNE RIJEČI: acebutolol; analiza vode; atenolol; Chirobiotic V kolona; Češka; enantioseparacija; HPLC; Hrvatska; 
labetalol; metoprolol
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